Pfizer offers a 5.7% dividend yield despite concerns over a 436% payout ratio, with a strong market position and promising drug pipeline.

Pfizer offers a 5.7% dividend yield, attracting investors despite concerns over a high payout ratio of 436%, the highest in its sector. While this raises sustainability issues, Pfizer's strong market position, commitment to maintaining dividends, and a promising drug pipeline suggest potential for recovery. The company aims to improve cash flow through a $4 billion savings plan, making it a noteworthy option for yield-seeking investors, albeit with caution advised.

September 15, 2024
3 Articles

Further Reading